Large Language Models To Improve the Quality of Care of Cardiology Patients
Launched by STANFORD UNIVERSITY · Apr 17, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well large language models (AI tools) can help cardiologists make decisions about treating patients with heart conditions like Hypertrophic Cardiomyopathy (HCM) and other genetic heart diseases. In this study, cardiologists will be divided into two groups: one will use AI assistance while managing real patient cases, and the other will rely on traditional methods. The goal is to see if using AI improves the quality of care that patients receive.
To participate in this trial, cardiologists must be board certified or board eligible, meaning they have completed their training and are qualified to practice. Those who are not currently seeing patients will not be included. Participants can expect to work on actual patient cases and have their decisions evaluated by experienced cardiologists to see how well they did. This study is currently recruiting participants, and anyone interested should check if they meet the eligibility criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Board certified or board eligible Cardiologist.
- Exclusion Criteria:
- • Not currently practicing clinically
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Euan A Ashley, BSc, MB ChB, DPhil
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported